/Companies

Genomill

Turku, FI · Founded 2016 · 12 employees on LinkedIn · 1 known investors

Find your way into Genomill

Sign up to see every warm intro you have to Genomill

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Genomill team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

GenomILL develops precision diagnostic technologies using genomic analysis. The company serves clinical and research customers seeking advanced molecular diagnostics.

Founders & leadership

Genomill was founded in 2016 by Manu Tamminen, Sami Savisalo, Juuso Blomster, and Jukka Laine.

MTManu Tamminen
Manu TamminenCEO, Co-FounderManu Tamminen is a molecular biologist with expertise in next-generation DNA sequencing platforms. He is co-founder and CEO of Genomill, which develops precision diagnostic technologies using genomic analysis.
SSSami Savisalo
Sami SavisaloChair of the Board, Co-founderSami Savisalo is a business lawyer with two decades of experience in legal matters for Finnish growth companies and listed entities, with specialization in venture capital, mergers and acquisitions, and intellectual property across healthcare, biotech, and deep tech sectors. He is chair of the board and co-founder of Genomill, which develops precision diagnostic technologies using genomic analysis.
JBJuuso Blomster
Juuso BlomsterBoard Member, Co-FounderJuuso Blomster holds an MD and PhD and trained as a cardiologist before co-founding Genomill, which develops precision diagnostic technologies using genomic analysis.
JLJukka Laine
Jukka LaineMedical Advisor, Co-FounderJukka Laine is a pathology researcher and physician who trained under Prof. Timo Nevalainen studying inflammatory and antibacterial signaling, later focusing on genetics in neonatal disease and cancer susceptibility. He holds a position as Docent in experimental pathology and pediatric pathology specialist at Turku University Hospital, has published over 80 peer-reviewed scientific papers, and co-founded Modern Diagnostics and Genomill Health to develop NGS-based diagnostic technologies for cancer monitoring and hereditary disease detection.

Investors · 1

Frequently asked questions

What does Genomill do?
GenomILL develops precision diagnostic technologies using genomic analysis. The company serves clinical and research customers seeking advanced molecular diagnostics.
Who founded Genomill?
Genomill was founded by Manu Tamminen, Sami Savisalo, Juuso Blomster, Jukka Laine in 2016.
Who are Genomill's investors?
Genomill's investors include Voima Ventures.
Where is Genomill headquartered?
Genomill is headquartered in Turku, FI.